Piqray (Alpelisib) 300mg film-coated tablets
Condition : New
0
From UAE
To Germany
in 5-10 days
Description
How It Works
Piqray works by inhibiting a protein called phosphatidylinositol 3-kinase (PI3K). PI3K is involved in cell growth, survival, and metabolism. By blocking PI3K, Piqray helps slow down or stop the growth of cancer cells in patients with advanced breast cancer that have a specific genetic mutation known as PIK3CA mutation.Side Effects
- Hyperglycemia (high blood sugar)
- Nausea
- Fatigue
- Rash
- Diarrhea
- Decreased appetite
Indications
- Piqray is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.
Contra indications
- Hypersensitivity to alpelisib or any of the excipients
- Severe hepatic impairment
Price Comparison in Different Countries
Country | Price (USD) | Reference |
---|---|---|
United States | $12,000.00 | GoodRx |
United Kingdom | ?9,000.00 | NHS UK |
Australia | $15,000.00 AUD | Pharmaceutical Benefits Scheme Australia |
Canada | $13,000.00 CAD | MedBroadcast Canada |
Top 5 Global Brands
- Novartis
- Pfizer
- Roche
- Merck & Co.
- Sanofi
Related products
-
Uncategorized
Ivosidenib (Tibsovo): A Novel Treatment for Acute Myeloid Leukemia
Rated 0 out of 5Get Price